SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-183804
Filing Date
2008-08-26
Accepted
2008-08-26 06:02:30
Documents
3
Period of Report
2008-08-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15390
2 PRESS RELEASE DATED AUGUST 25, 2008 dex991.htm EX-99.1 6726
3 GRAPHIC g67123logo.jpg GRAPHIC 3822
  Complete submission text file 0001193125-08-183804.txt   29245
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858 623-5665 XT 158
TorreyPines Therapeutics, Inc. (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25571 | Film No.: 081037790
SIC: 2834 Pharmaceutical Preparations